Potentiation of tyramine action by 5-hydroxytryptamine in the dog heart.
نویسندگان
چکیده
منابع مشابه
An action of 5-hydroxytryptamine on adrenaline receptors.
Contractions of isolated strips of cat spleen due to 5-hydroxytryptamine, adrenaline, histamine and acetylcholine were antagonized by phenoxybenzamine. Responses to both 5-hydroxytryptamine and adrenaline were not blocked in strips which were protected by a high concentration of either 5-hydroxytryptamine or adrenaline throughout exposure to phenoxybenzamine. The contraction due to a large dose...
متن کاملCardiac effects of tyramine.
• Tyramino (p-hydroxyphenylethylamine), the product of decarboxylation of tyrosine, has been known for a number of years to have pharmacological activity as a pressor substance." In a preparation of the atrium of the cat's heart in Locke-Ringer solution, Ajidrus, in 1 924, showed that tyramine increased the rate aud amplitude of atrial contractions. In 1926, Tainter reported the circulatory eff...
متن کاملA Comparison of the Cardiovascular Effects of Biogenic Amines and Their Precursors in Newborn and Adult Dogs1’2
Piuvimii. , PHILIP J., JENNIFER M. H. LOGGIE AND THOMAS E. G m EY: A comparison of the cardiovascular effects of biogenic amines and their precursors in newborn and adult dogs. J. Pharmacol. Exp. Ther. 166: 293-298, 1969. There is relatively little information regarding the cardiovascular effects of the biogenic amines in newborn animals. In the present study the pressor and chronotropic respon...
متن کاملCardiac actions of glucagon.
Glucagon increased heart rate and contractile force in the anesthetized dog and increased isometric tension in the isolated dog papillary muscle. The positive inotropic and chronotropic responses were not abolished or reduced by previous administration of the beta-receptor blocking agent propranolol, in doses of 0.5 mg/kg. Glucagon increased the force and rate of cardiac contraction even when c...
متن کاملEditorimu Modification of Insulin and Sulfonylurea Hypoglycemia by M0n0am1ne-0x1dase Inhibitor Drugs
The moncamine-oxidase inhibitors (MAOI's) were introduced into therapeutics in 1957 and despite numerous toxic effects are in widespread use today.* The bulk of these drugs are employed by psychiatrists for the hospital and office treatment of depression. However, they also find a use in cardiology in the management of angina pectoris and hypertension. All the MAOI's possess in common the abili...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Japanese journal of pharmacology
دوره 28 1 شماره
صفحات -
تاریخ انتشار 1978